We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
24 hedge funds and large institutions have $65.1M invested in ADMA Biologics in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
26% more funds holding
Funds holding: 19 → 24 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $68.1M → $65.1M (-$3.01M)
Holders
24
Holders Change
+5
Holders Change %
+26.32%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
8
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$294K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$39.8K |
| 3 |
SIM
Spark Investment Management
New York
|
-$22.5K |
| 4 |
Goldman Sachs
New York
|
-$21.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.36K |
